Biomarin Pharmaceutical reported $127.06M in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 5.21M 0.51M
Acorda Therapeutics ACOR:US $ 11.32M 0.64M
Alexion Pharmaceuticals ALXN:US $ 125.4M 26.8M
Alnylam Pharmaceuticals ALNY:US $ 30.26M 7.23M
Amgen AMGN:US $ 1637M 147M
Bayer BAYN:GR € 4546M 152M
Biogen BIIB:US $ 459.7M 18.4M
Biomarin Pharmaceutical BMRN:US $ 127.06M 6.9M
Bluebird Bio BLUE:US $ 15.3M 13.02M
Gilead Sciences GILD:US $ 1390M 29M
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
Insmed INSM:US $ 10.84M 993K
Intercept Pharmaceuticals ICPT:US $ 0.62M 0.19M
IONIS PHARMACEUT IONS:US $ 2.96M 0.38M
Moderna Inc MRNA:US 750M 557M
Neurocrine Biosciences NBIX:US $ 3.1M 0.2M
Ptc Therapeutics PTCT:US $ 7.36M 1.75M
Puma Biotechnology PBYI:US $ 11.97M 17.59M
Regeneron Pharmaceuticals REGN:US $ 693.7M 385.7M
Sarepta Therapeutics SRPT:US $ 19.52M 2.83M
Seattle Genetics SGEN:US $ 78.09M 13.96M
Ultragenyx Pharmaceutical RARE:US $ 3.14M 2.05M
United Therapeutics UTHR:US $ 37.2M 14.2M
Vertex Pharmaceuticals VRTX:US $ 227.97M 35.64M
YTE INCY:US $ 32.63M 8.81M